Blue-Chip

Top 5 Picks for 2024 - SUN, MTS, IPH, APM, CUV

December 29, 2023 | Team Kalkine
Top 5 Picks for 2024 - SUN, MTS, IPH, APM, CUV

SUN:ASX
Investment Type
Large-cap
Risk Level
Action
Rec. Price (AU$)
MTS:ASX
Investment Type
Mid - Cap
Risk Level
Action
Rec. Price (AU$)
IPH:ASX
Investment Type
Small-Cap
Risk Level
Action
Rec. Price (AU$)
APM:ASX
Investment Type
Small-Cap
Risk Level
Action
Rec. Price (AU$)
CUV:ASX
Investment Type
Small-Cap
Risk Level
Action
Rec. Price (AU$)

Company Overview: Suncorp Group Limited (ASX: SUN) provides insurance and banking products and services through various brands in Australia and New Zealand. Its segments include Insurance (Australia), Suncorp Bank and Suncorp New Zealand. Metcash Limited (ASX: MTS) is an Australian wholesale distribution and marketing company operating through the food, grocery, liquor, and hardware segments. IPH Limited (ASX: IPH) provides services related to the provision of filing, prosecution, enforcement as well as management of patents, designs, trademarks in Australia, New Zealand, Asia, and other countries. IPH is the holding company of AJ Park, Griffith Hack, Pizzeys, Smart & Biggar, Spruson & Ferguson and Applied Marks. APM Human Services International Limited (ASX: APM) is an international health and human services provider. Each financial year, APM supports more than 2 million people of all ages and stages of life from over 1,700 sites spanning 11 countries. Global specialty pharmaceutical group Clinuvel Pharmaceuticals Limited (ASX: CUV) is engaged in the development and commercialision of treatments for patients with genetic, metabolic, systemic, and life-threatening, acute disorders. Kalkine’s Daily Report covers the Key Financial Metrics, Risks, Outlook, Technical Analysis along with the Valuation, Target Price, and Recommendation on the stock.

Suncorp Group Limited (ASX: SUN)

Section 1.0: Key Metrics in Pictures

Having looked at the key financial ratios above the below sections provide an in-depth fundamental, and technical analysis on this Insurance stock along with recommendations, technical support and resistance levels and indicative stop-loss.

Section 2.0: Suncorp Group Limited (‘Buy’ at AUD 13.850, closing market price as on 29 December 2023)

2.1 Company Details

2.2 Stock Recommendation, and Technical Guidance

The stock has increased by ~2.67% in 6 months and over the last 9 months, it has increased by ~14.37%. The stock has a 52-week low and 52-week high of AUD 11.455 and AUD 14.410, respectively and is currently trading above the average of 52-week high-low average.

Metcash Limited (ASX: MTS)

Section 1.0: Key Metrics in Pictures

Having looked at the key financial metrics above the below sections provide in-depth fundamental, and technical analysis on this Consumer Staples stock along with recommendation, technical support, and resistance level & indicative stop-loss.

Section 2.0: Metcash Limited (‘Buy’ at AUD 3.490 closing market price per share as on 29 December 2023)

2.1 Company Details

2.2 Valuation, Technical Summary & Stock Recommendation

The stock has witnessed a dip of ~7.6% in the last three months, and over the last one year, it has decreased by ~11.8%. The stock has a 52-week low and 52-week high of AUD 3.410 and AUD 4.240, respectively and is currently trading below the 52-week high-low average. MTS was last covered in a report dated ‘20 November 2023’.

IPH Limited (ASX: IPH) 

Section 1.0: Key Metrics in Pictures

Having looked at the key financial ratios above the below sections provide an in-depth fundamental, and technical analysis on this one ASX-listed Professional Services along with recommendations, technical support and resistance levels and indicative stop-loss.

Section 2.0: IPH Limited (‘Speculative Buy’ at AUD 6.410 closing market price per share as on 29 December 2023)

2.1 Company Details

2.2 Stock Recommendation and Valuation

The stock has witnessed a dip of ~13.5% in last three months, and over the last one year, it has decreased by ~26.6%The stock has a 52-week low and 52-week high of AUD 6.325 and AUD 8.990, respectively and is currently trading below the 52-week high-low average. IPH was last covered in a report dated ’14 December 2023.

APM Human Services International Limited (ASX: APM)

Section 1.0: Key Metrics in Pictures

Having looked at the key financial ratios above the below sections provide an in-depth fundamental, and technical analysis on this Professional Services’ stock along with recommendations, technical support and resistance levels and indicative stop-loss.

Section 2.0: APM Human Services International Ltd - (‘Speculative Buy’ at AUD 1.225, closing market price as on 29 December 2023)

Company Details

2.3 Stock Recommendation, and Technical Guidance

The stock has fallen around 19% in the last 1 month and plunged around 42% in the past 6 months. The stock has a 52-week low and 52-week high of AUD 1.080 and AUD 2.640, respectively and is currently trading below the average of 52-week high-low average. APM was last covered in a report dated ‘14 December 2023’.

 (Source: REFINTIV; Analysis by Kalkine Group)

Clinuvel Pharmaceuticals Limited (ASX: CUV)

Section 1.0: Key Metrics in Pictures

Having looked at the key financial metrics above the below sections provide in-depth fundamental, and technical analysis on this Biotechnology Stock along with recommendation, technical support, and resistance level & indicative stop-loss.

Section 2.0: Clinuvel Pharmaceuticals Limited (‘Speculative Buy’ at AUD 16.000 closing market price per share as on 29 December 2023)

2.2 Company Details

2.2 Valuation, Technical Summary & Stock Recommendation

The stock has witnessed a gain of ~8.7% in the last three months, and over the last one year, it has decreased by ~25.8%. The stock has a 52-week low and 52-week high of AUD 13.970 and AUD 28.720, respectively and is currently trading below the 52-week high-low average. CUV was last covered in a report dated ‘16 November 2023’.

Markets are trading in a highly volatile zone currently due to certain macro-economic and geopolitical tensions prevailing. Therefore, it is prudent to follow a cautious approach while investing.

Note 1: Past performance is not a reliable indicator of future performance.

Note 2: The reference date for all price data, currency, technical indicators, support, and resistance levels is 29 December 2023. The reference data in this report has been partly sourced from REFINITIV.

Note 3: Investment decisions should be made depending on an individual's appetite for upside potential, risks, holding duration, and any previous holdings. An 'Exit' from the stock can be considered if the Target Price mentioned as per the Valuation and or the technical levels provided has been achieved and is subject to the factors discussed above.

Note 4: Dividend Yield may vary as per the stock price movement.

Technical Indicators Defined: -

Support: A level at which the stock prices tend to find support if they are falling, and a downtrend may take a pause backed by demand or buying interest. Support 1 refers to the nearby support level for the stock and if the price breaches the level, then Support 2 may act as the crucial support level for the stock.

Resistance: A level at which the stock prices tend to find resistance when they are rising, and an uptrend may take a pause due to profit booking or selling interest. Resistance 1 refers to the nearby resistance level for the stock and if the price surpasses the level, then Resistance 2 may act as the crucial resistance level for the stock.

Stop-loss: It is a level to protect further losses in case of unfavourable movement in the stock prices.



Disclaimer-

This report has been issued by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and prepared by Kalkine and its related bodies corporate authorised to provide general financial product advice. Kalkine.com.au and associated pages are published by Kalkine.

Any advice provided in this report is general advice only and does not take into account your objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Statement or other offer document for the securities or other financial products referred to in Kalkine reports. You should obtain a copy of the relevant Product Disclosure Statement, Information Statement or offer document and consider the statement or document before making any decision about whether to acquire the security or product.

You should also seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice in this report or on the Kalkine website. Not all investments are appropriate for all people.

The information in this report and on the Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of information contained in its reports, newsletters and websites. All information represents our views at the date of publication and may change without notice.

Kalkine does not guarantee the performance of, or returns on, any investment. To the extent permitted by law, Kalkine excludes all liability for any loss or damage arising from the use of this report, the Kalkine website and any information published on the Kalkine website (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine hereby limits its liability, to the extent permitted by law, to the resupply of services. Please note past performance is neither an indicator nor a guarantee of future performance.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this report or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website including entities covered in this Report.